European prize for mobile vaccination units The Netherlands’ mobile vaccination units (prikbussen) have been selected as a best-practice method for the European project ‘Overcoming Obstacles to Vaccination’.
RIVM modelling for COVID-19 reviewed by international experts An international audit committee of scientific experts, commissioned by the RIVM Scientific Advisory Board, reviewed the institute’s COVID-19 data analytics and modelling work. These models and data formed a scientific basis for recommendations by the Outbreak Management Team (OMT) and others on COVID-19 control measures in the Netherlands.
Side effect reports National Immunisation Programme 2021 Last year, the Netherlands Pharmacovigilance Centre Lareb received 1,462 reports of possible side effects from vaccines administered under the National Immunisation Programme. As was the case in previous years, no new, disconcerting side effects have
Vulnerable groups in society have been hit harder by the COVID-19 pandemic Some vulnerable groups in society have been hit harder by the COVID-19 pandemic than less vulnerable groups. These include young people (up to 24 years) who have physical or mental problems or come from low-income families.
Operations postponed due to pandemic result in 320,000 healthy life years lost The COVID-19 pandemic caused over 305,000 operations to be postponed in 2020 and 2021 in the Netherlands.
Participation in National Immunisation Programme shows slight decrease Participation in the National Immunisation Programme has fallen slightly, showing a decrease of 1 to 2 percentage points.